Sun Pharmaceutical Industries Ltd is buying US-based immunotherapy and oncology firm Checkpoint Therapeutics Inc. for $355 million. A bird flies past the logo of Sun Pharma installed on the facade ...
I write about Asia's richest, fast-growing businesses, and startups. Sun Pharmaceutical Industries—controlled by Indian billionaire Dilip Shanghvi—has agreed to buy U.S.-based immunotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback